drugset / Trial / NCT02066545

Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris

NCT02066545 ↗

Phase 2 Completed 327 enrolled Maruho Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to evaluate the safety and efficacy of once-daily topical application of CLS001 1%, 1.75% and 2.5% topical gel compared to vehicle topical gel in subjects with inflammatory acne vulgaris

Timeline

Start
2014-04
Primary completion
2014-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject CLS001 Unknown 1 % Topical
Subject CLS001 Unknown 1.75 % Topical
Subject CLS001 Unknown 2.5 % Topical

Indications